Kim, J. S., Lee, G., Lee, M., Youk, J., Lee, H., Lim, S., Kim, S., Jeon, Y. K., Park, C., Kim, T. M. (2026). SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)—The Korean Cancer Study Group LY22-07.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2009